EU approves Tamiflu for children
The European Union has approved the use of Tamiflu to prevent flu in children. The antiviral drug was cleared by the FDA for children in December. The twin approvals are aimed at giving doctors another weapon to stop the spread of influenza. Children are much more likely than seniors to contract and die from the flu. Governments around the world have also been stockpiling Tamiflu in the hope that it would help protect people in the event of a worldwide bird flu pandemic.
- read this report from the Financial Times
ALSO: A 15-year-old Iraqi girl has died of avian flu, marking the spread of the virus to another country. Report
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
